NCT02436486

Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

Interventional, Randomised, Double-blind, Placebo- and Positive Controlled, Single-dose, Cross-over Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 76 (actual)
• Sponsor: H. Lundbeck A/S · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To evaluate the effect of idalopirdine (120 and 360 mg) on cardiac repolarisation in healthy men.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Placebo	Capsules, orally, single dose
DRUG	ldalopirdine 120 mg	Two 60 mg encapsulated film-coated tablets, orally, single dose
DRUG	Idalopirdine 360 mg	Four 90 mg encapsulated film-coated tablets, orally, single dose
DRUG	Moxifloxacin 400 mg	Encapsulated tablets, orally, single dose

Timeline

• Start date: 2015-05-01
• Primary completion: 2015-08-01
• First posted: 2015-05-06
• Last updated: 2015-09-22

Locations

1 site across 1 country: France